In addition, PUS1 may participate in DNA repair, E2F targeting, MYC targeting, and the G2M checkpoint and promote malignant transformation in non-small cell lung cancer (NSCLC) through mcm5 or XPO1 [118]. This evidence concerns the gene XPO1 and non-small cell lung carcinoma.